华熙生物董事长赵燕：2026年AI将全面融入企业

Core Insights - The chairman of Huaxi Biological, Zhao Yan, stated that 2026 will mark the year when AI truly enters the company, with plans for comprehensive integration into management and operations [1] - The company anticipates the emergence of hundreds of silicon-based intelligent agents to optimize management over carbon-based individuals and enhance various business scenarios [1] - Huaxi Biological will focus on two core areas: intervention in aging and regeneration of tissues, leveraging foundational technologies such as glycoscience and synthetic biology to deepen its engagement in the health sector [1] Business Strategy - AI will be utilized to provide consumer expert services, assist in content generation, and connect robots in production to improve efficiency [1] - The integration of AI is expected to reshape industry logic and elevate operational efficiency [1]